Kali Delzompo
Payments from drug & device makers
Across 143 payments — averaging $23.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$642
- Novo Nordisk$591
- Boehringer Ingelheim$378
- GSK$184
- Lilly USA, LLC$174
- Abbott$158
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,428100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $642 |
| Novo Nordisk | 36 | $591 |
| Boehringer Ingelheim | 17 | $378 |
| GSK | 9 | $184 |
| Lilly USA, LLC | 8 | $174 |
| Abbott | 7 | $158 |
| Inspire Medical Systems, Inc. | 1 | $154 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Amgen | 2 | $104 |
| Gilead | 4 | $87 |
| Exact Sciences | 5 | $85 |
| AbbVie | 4 | $80 |
| Novartis | 3 | $77 |
| Pfizer | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Dexcom, Inc. | 2 | $51 |
| Boston Scientific | 2 | $43 |
| Renalytix AI, Inc. | 1 | $38 |
| Tactile Systems Technology Inc | 1 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Edwards Lifesciences | 1 | $27 |
| Bayer | 2 | $27 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Sanofi | 1 | $24 |
| Shield Therapeutics Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Mannkind Corporation | 1 | $12 |
| Qiagen, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$154
- NURTEC ODT$125
- BREZTRI$122
- AIRSUPRA$104
How this compares
$3,428 in reported general payments places this provider in the 75th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $485 |
| Levothyroxine Sodium | 17 | $388 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $346 |
| Cephalexin | 22 | $267 |
| Methylprednisolone | 30 | $217 |
| Atorvastatin Calcium | 13 | $181 |
| Doxycycline Hyclate | 19 | $171 |
| Ofloxacin | 14 | $142 |
| Rosuvastatin Calcium | 13 | $85 |
| Lisinopril | 18 | $67 |
| Baclofen | 11 | $61 |
| Prednisone | 16 | $38 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $0 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPaxlovid | $63 | $013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 748 medical providers in Arizona.
Other medical in Tempe
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
- Lakeisha ColterPhoenix$48K
- Amy IngersollPhoenix$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.